Biotech data science co Elucidata raises $16-M led by Eight Roads Ventures
Biotech data firm Elucidata has raised USD 16 million in a Series A round led by Eight Roads Ventures, with participation from F-Prime Capital, IvyCap Ventures, and Hyperplane Venture Capital. The fresh capital will be used to deepen product capabilities in the fields of translational drug research and allied markets, scale go-to-market initiatives and accelerate global expansion of operations. Currently, Elucidata is working on research and development (R&D) through its data-centric Machine Learning Operations (ML-Ops) platform Polly. This platform allows R&D teams of firms to access clean, curated biomolecular data that can be analyzed over a graphical user interface (GUI) or through a program.
Want to receive such news items in your inbox? Click Here to sign up for a trial.